Latest Safety News

OM Holdings reported steady revenue of US$309.3 million in 1H 2025 despite a sharp EBITDA decline and net loss, while maintaining a strong cash position and advancing sustainability goals.

Advanced Braking Technology (ABT) reported robust FY25 financial results marked by revenue growth and improved profitability, while advancing its strategic roadmap focused on mining safety innovations and global market expansion.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Robotics innovator FBR Limited has closed its Share Purchase Plan, securing approximately $700,000 in applications and preparing to issue new shares by early September.

Pure Hydrogen Corporation has signed a Letter of Intent with California's GTS Group to supply hydrogen-powered heavy vehicles, marking a strategic push into the North American market.

Synertec Corporation has secured another order from Santos Limited for its Powerhouse renewable microgrid system at a remote Queensland gas site, reinforcing its role in decarbonising industrial energy supply.

Metgasco's Production Uplift Program has successfully increased raw gas production at the Odin and Vali fields to 2.9 million cubic feet per day through effective scale removal, with Phase 2 operations set to begin in September.

Lightning Minerals is set to commence a significant diamond drilling program targeting high-grade gold zones at its newly acquired Mt Turner project in Queensland, aiming to unlock deeper mineralisation along the Drummer Fault.

Island Pharmaceuticals has formally requested a Type C meeting with the US FDA to discuss accelerating approval of its antiviral Galidesivir for Marburg virus using the Animal Rule pathway.

Anson Resources has submitted a permit application for a production-scale disposal well at its Green River Lithium Project, marking a key step toward full-scale lithium production in Utah. This well will support both demonstration and future operations, enhancing geological understanding and resource modeling.

Recce Pharmaceuticals reported a 21% increase in net loss to $21.4 million for FY2025, driven by intensified R&D spending. The company secured key regulatory approvals for Phase 3 trials of its lead anti-infective gel and bolstered its financial position with significant capital raises and grants.

Catalyst Metals Limited reported record FY2025 financial results driven by stable operations at the Plutonic Gold Belt and a buoyant gold price environment. The company plans to double annual gold production to 200koz through development of new mines and expanded exploration.